CHSYF
Price
$1.35
Change
-$0.17 (-11.18%)
Updated
Aug 1 closing price
Capitalization
4.46B
CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
3.98M
Interact to see
Advertisement

CHSYF vs CNADF

Header iconCHSYF vs CNADF Comparison
Open Charts CHSYF vs CNADFBanner chart's image
China Medical System Holdings
Price$1.35
Change-$0.17 (-11.18%)
Volume$1K
Capitalization4.46B
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization3.98M
CHSYF vs CNADF Comparison Chart in %
Loading...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHSYF vs. CNADF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHSYF is a Hold and CNADF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CHSYF: $1.35 vs. CNADF: $0.06)
Brand notoriety: CHSYF and CNADF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CHSYF: 52% vs. CNADF: 100%
Market capitalization -- CHSYF: $4.46B vs. CNADF: $3.98M
CHSYF [@Pharmaceuticals: Generic] is valued at $4.46B. CNADF’s [@Pharmaceuticals: Generic] market capitalization is $3.98M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHSYF’s FA Score shows that 1 FA rating(s) are green whileCNADF’s FA Score has 1 green FA rating(s).

  • CHSYF’s FA Score: 1 green, 4 red.
  • CNADF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHSYF is a better buy in the long-term than CNADF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHSYF’s TA Score shows that 0 TA indicator(s) are bullish while CNADF’s TA Score has 1 bullish TA indicator(s).

  • CHSYF’s TA Score: 0 bullish, 3 bearish.
  • CNADF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, CNADF is a better buy in the short-term than CHSYF.

Price Growth

CHSYF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while CNADF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.46B) has a higher market cap than CNADF($3.98M). CHSYF has higher P/E ratio than CNADF: CHSYF (14.10) vs CNADF (11.57). CNADF YTD gains are higher at: 78.571 vs. CHSYF (45.052). CHSYF has higher annual earnings (EBITDA): 2.05B vs. CNADF (1.54M). CHSYF has more cash in the bank: 5.97B vs. CNADF (948K). CNADF has less debt than CHSYF: CNADF (9.18M) vs CHSYF (748M). CHSYF has higher revenues than CNADF: CHSYF (7.86B) vs CNADF (17.2M).
CHSYFCNADFCHSYF / CNADF
Capitalization4.46B3.98M112,164%
EBITDA2.05B1.54M132,513%
Gain YTD45.05278.57157%
P/E Ratio14.1011.57122%
Revenue7.86B17.2M45,698%
Total Cash5.97B948K629,536%
Total Debt748M9.18M8,147%
FUNDAMENTALS RATINGS
CHSYF: Fundamental Ratings
CHSYF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
43
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
16

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CHSYFCNADF
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
40%
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
9%
Bullish Trend 3 days ago
29%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
9%
Bullish Trend 3 days ago
33%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
11%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DIVI37.070.33
+0.90%
Franklin Intl Core Div Tlt Idx ETF
DJAN42.030.08
+0.18%
FT Vest US Equity Dp Bffr ETF Jan
PSMR29.220.05
+0.18%
Pacer Swan SOS Moderate (April) ETF
SEF31.28-0.21
-0.68%
ProShares Short Financials
TSMX45.11-1.18
-2.55%
Direxion Daily TSM Bull 2X Shares

CHSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHSYF has been loosely correlated with CNADF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CHSYF jumps, then CNADF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
CNADF - CHSYF
38%
Loosely correlated
N/A
SBFM - CHSYF
30%
Poorly correlated
-3.95%
SXTC - CHSYF
23%
Poorly correlated
+2.52%
TKNO - CHSYF
22%
Poorly correlated
+4.84%
CANN - CHSYF
7%
Poorly correlated
+2.15%
More

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with CHSYF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then CHSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
CHSYF - CNADF
38%
Loosely correlated
N/A
ZTS - CNADF
24%
Poorly correlated
+1.68%
CPHI - CNADF
20%
Poorly correlated
-3.90%
ESAIY - CNADF
5%
Poorly correlated
-0.23%
HLNCF - CNADF
4%
Poorly correlated
-3.57%
More